RxDoctor Payments Data

Louis Conte, DO

Plastic Surgery within the Head & Neck · Roselle Park, NJNPI 1952356651

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $558, 2.4 times the $234 reported in 2019.

$1,965in general payments, 2019–2025

Across 90 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$469
  • GSK$436
  • Regeneron Healthcare Solutions, Inc.$365
  • Merz North America, Inc.$175
  • Alk-abello, Inc$151
  • Sanofi$120
  • plus $249 from 7 others

What the payments were for

  • Food & beverage$1,86795%
  • Education$975%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$157,819
Medicare patients
554
Services billed
1,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone26$2,220
Fluticasone Propionate158$2,218
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort43$1,944
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,673
Olopatadine Hcl22$1,629
Mometasone Furoate103$1,349
Azelastine Hcl34$911
Albuterol Sulfate HfaAlbuterol Sulfate12$842
Omeprazole49$777
Levothyroxine Sodium33$485
Ofloxacin18$481
Methylprednisolone62$409
Doxycycline Hyclate38$389
Levocetirizine Dihydrochloride44$359
Montelukast Sodium17$255

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Roselle Park

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →